Quick Answer
Acurx Pharmaceuticals, Inc. reported Shares Outstanding of 2.35 million shares for fiscal year 2025.
Acurx Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.35M | +175.8% |
| 2024 | 851,534 | -94.1% |
| 2023 | 14.47M | +24.4% |
| 2022 | 11.63M | +13.8% |
| 2021 | 10.22M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.80M | -89.3% | +22.4% |
| June 30, 2025 | 1.47M | -90.8% | -93.4% |
| March 31, 2025 | 22.40M | +42.1% | +2530.3% |
| December 31, 2024 | 851,534 | -94.1% | -94.9% |
| September 30, 2024 | 16.77M | +29.0% | +4.8% |
| June 30, 2024 | 16.00M | +23.0% | +1.5% |
| March 31, 2024 | 15.76M | +35.0% | +8.9% |
| December 31, 2023 | 14.47M | +24.4% | +11.3% |
- Acurx Pharmaceuticals, Inc. showed an increase of +175.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Acurx Pharmaceuticals, Inc.’s shares outstanding has declined by 77.0% (from 10.22 million shares to 2.35 million shares).
- The most recent figure is from Acurx Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: